Research programme: astaxanthin prodrugs - Cardax PharmaceuticalsAlternative Names: CDX-085; Heptax; XanCor
Latest Information Update: 19 Nov 2015
At a glance
- Originator Cardax Pharmaceuticals
- Class Anti-inflammatories; Antineoplastics; Xanthophylls
- Mechanism of Action Antioxidants; Oxygen radical scavengers
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Hypertriglyceridaemia; Liver disorders; Metabolic syndrome; Rheumatoid arthritis; Thrombosis